The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AIDX | N/A | N/A | N/A | -38% |
| S&P | +12.95% | +76.86% | +12.07% | +1% |
No news articles found for 20/20 Biolabs.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $417.98K | 15.8% |
| Gross Profit | $145.07K | 500.9% |
| Gross Margin | 34.71% | 28.0% |
| Employees | 20 | 0.0% |
| Net Income | -$825.54K | 55.9% |
| EBITDA | -$780.95K | 57.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $1.14M | 0.0% |
| Accounts Receivable | $136.87K | 0.0% |
| Inventory | 0.1 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $986.46K | 0.0% |
| Short Term Debt | $173.35K | 0.0% |
No data available for this period.
| Q4 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$536.45K | 0.0% |
| Operating Free Cash Flow | -$536.45K | 0.0% |
| Metric | Q4 2024 | Q3 2025 | YoY Change |
|---|---|---|---|
| Total Debt | $839.55K | $1.16M | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
